4-demethoxydaunorubicin (4-DMDR) HCl is primarily used in cancer research and treatment, particularly in the study of chemotherapy agents. It is an anthracycline derivative and has shown potential as an antitumor agent. Its mechanism of action involves intercalating DNA, thereby inhibiting the replication of cancer cells and inducing apoptosis. This compound has been investigated for its efficacy in treating various types of cancers, including leukemia and solid tumors. Researchers have also explored its use in combination therapies to enhance its anticancer effects while minimizing resistance development. Additionally, 4-DMDR HCl is utilized in preclinical studies to better understand the structure-activity relationships of anthracyclines, aiding in the development of more effective and less toxic chemotherapeutic drugs.